Due to the not fully understood, complex pathomechanism of AD and numerous clinical failures of anti-amyloid and anti-tau drugs, it is necessary to look at strategies involving modifying factors connected with the style of life or dietary factors which potentially would counteract the development of neurodegenerative changes or delay AD progression. This evidence concerns the gene MAPT and Alzheimer disease.